1. Introduction

molecules

Molecules

1420-3049

MDPI

10.3390/molecules17044400

molecules-17-04400

Review

Honey: A Novel Antioxidant

Erejuwa

Omotayo O.

* Sulaiman

Siti A.

Ab Wahab

Mohd S.

Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia; Email: sbsamrah@kb.usm.my (S.A.S.); msuhaimi@kb.usm.my (M.S.A.W.)

* Author to whom correspondence should be addressed; Email: erejuwa@gmail.com; Tel.: +609-7666-877; Fax: +609-7653-370.

12 04 2012

04 2012

17 4 4400 4423 25 02 2012 30 03 2012 01 04 2012

2012

This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).

The global prevalence of chronic diseases such as diabetes mellitus, hypertension, atherosclerosis, cancer and Alzheimer's disease is on the rise. These diseases, which constitute the major causes of death globally, are associated with oxidative stress. Oxidative stress is defined as an “imbalance between oxidants and antioxidants in favor of the oxidants, potentially leading to damage”. Individuals with chronic diseases are more susceptible to oxidative stress and damage because they have elevated levels of oxidants and/or reduced antioxidants. This, therefore, necessitates supplementation with antioxidants so as to delay, prevent or remove oxidative damage. Honey is a natural substance with many medicinal effects such as antibacterial, hepatoprotective, hypoglycemic, reproductive, antihypertensive and antioxidant effects. This review presents findings that indicate honey may ameliorate oxidative stress in the gastrointestinal tract (GIT), liver, pancreas, kidney, reproductive organs and plasma/serum. Besides, the review highlights data that demonstrate the synergistic antioxidant effect of honey and antidiabetic drugs in the pancreas, kidney and serum of diabetic rats. These data suggest that honey, administered alone or in combination with conventional therapy, might be a novel antioxidant in the management of chronic diseases commonly associated with oxidative stress. In view of the fact that the majority of these data emanate from animal studies, there is an urgent need to investigate this antioxidant effect of honey in human subjects with chronic or degenerative diseases.

honey antioxidant oxidative stress chronic diseases, kidney pancreas liver plasma testis

1. Introduction

In the last couple of decades, there has been an increase in the global prevalence of degenerative or chronic diseases such as diabetes mellitus, hypertension, cancer, Alzheimer's disease, atherosclerosis and heart disease [1,2]. These diseases are now the major causes of death globally [1,2]. Recent evidence implicates the role of oxidative stress in the pathogenesis and/or complications of these disorders [3,4]. Oxidative stress is defined as an “imbalance between oxidants and antioxidants in favor of the oxidants, potentially leading to damage” [5]. It is caused by increased production and/or reduced removal of reactive species by the antioxidant defenses. Oxidative stress causes oxidative damage - “the biomolecular damage caused by attack of reactive species upon the constituents of living organisms” [6]. Oxidative damage to cellular components impairs physiological functions. Reactive species can be reactive oxygen species (ROS) or reactive nitrogen species (RNS) [5,6]. Reactive oxygen species include superoxide (O₂^•−), hydroxyl (^•OH) and hydrogen peroxide (H₂O₂), while RNS are nitric oxide (NO), nitrogen dioxide (NO₂^•−) and peroxynitrite (OONO⁻) [5,6]. They are produced by aerobic organisms as byproducts of metabolism such as during mitochondrial electron transport chain or as a result of accidents of chemistry such as the autoxidation of unstable biomolecules (dopamine) [5,7]. Reactive species may also be produced in response to inflammation during which phagocytes release ROS to kill invading bacteria [5,7]. The ability of cells to scavenge excess reactive species is largely dependent on the efficiency of the overall antioxidant defense system [6,7]. This antioxidant defense network consists of endogenous and exogenous antioxidants. The endogenous antioxidants comprise the enzymatic antioxidants such as superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) and non-enzymatic antioxidants including glutathione (GSH), vitamins C and E as well as small molecules [6]. The exogenous antioxidants comprise the micronutrients and other exogenously administered antioxidants [5,6]. As defined by Halliwell and Gutteridge, an antioxidant is “any substance that delays, prevents or removes oxidative damage to a target molecule” [6]. Available evidence indicates that individuals with chronic or degenerative diseases are more susceptible to oxidative stress and damage because they have elevated levels of oxidants and/or reduced antioxidants [3,4]. Therefore, it has been posited that antioxidant supplementation in such individuals may be beneficial [8,9,10].

Honey, a natural product formed from nectar by honeybees, has been a subject of renewed research interest in the last few years. Evidence indicates that honey can exert several health-beneficial effects such as gastroprotective [11], hepatoprotective [12], reproductive [13,14], hypoglycemic [15], antioxidant [15], antihypertensive [16], antibacterial [17], anti-fungal [18] and anti-inflammatory [19] effects. It consists of primarily sugars such as monosaccharides, disaccharides, oligosaccharides and polysaccharides [20,21,22]. It contains enzymes such as glucose oxidase, diastase, invertase, catalase and peroxidase [20]. Honey also contains other bioactive constituents such as organic acids, ascorbic acid, trace elements, vitamins, amino acids, proteins and Maillard reaction products [20]. This review presents a synopsis of findings that indicate honey is a novel antioxidant. The data presented suggest that honey, administered alone or in combination with conventional therapy, might be of therapeutic benefits in the management of chronic diseases commonly associated with oxidative stress. This paper, which is a comprehensive review of the current literature, highlights the (potential) beneficial effects of honey based on its ability to ameliorate oxidative stress in different tissues, organs, body fluids or compartments. These include gastroprotective, hepatoprotective, renoprotective as well as its protective effect in the pancreas, eye, testis and plasma. Considering that the bulk of these data emanate from animal studies, it is worthwhile to perform clinical studies that investigate if this antioxidant effect of honey can be extrapolated to human subjects with chronic diseases. The molecular structures of some of the biologically active constituents such as fructose and oligosaccharides which may play a role in the hypoglycemic or antidiabetic effect of honey are shown in Figure 1 [21,22,23,24,25].

Figure 1

Molecular structures of fructose and oligosaccharides present in honey.

2. Honey: A Novel Antioxidant–Evidence from <italic>in Vitro</italic> Studies

The in vitro antioxidant properties of natural or synthetic agents are measured in the form of antiradical activity using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging assay, oxygen radical absorbance capacity (ORAC) assay and ferric reducing antioxidant power (FRAP) assay [26,27]. Using these tests, different varieties of honey from various countries and geographical regions have been shown to exhibit high antioxidant properties. Turkish red pine honey produced by Marchalina hellenica was reported to scavenge DPPH effectively, suggestive of its antiradical activities [28]. Some Saudi Arabian honey samples were demonstrated to exhibit antioxidant activities [29]. Similar antioxidant properties were also reported for Peruvian honey [30]. Australian honey produced by the stingless bees Trigona carbonaria was reported to have high antioxidant properties [31]. Malaysian tualang honey produced by the giant Asian bees Apis dorsata has been shown to exhibit good antioxidant and antiradical activities [32,33,34]. Antioxidant activities have also been documented for American buckwheat honey [35], Croatian oak honeydew honey [36], Spanish honey [37], Portugal honey [38], Cuban honey [39], Venezuelan honey [40] and Ecuadorian honey [41]. The antioxidant activity of honey is generally attributed to its phenolic compounds and flavonoids [33,35,42,43]. Findings from a recent study suggest that gamma irradiation may increase the antioxidant capacities and total phenolic contents in honey [27]. The main phenolic and flavonoid compounds in honey include ellagic acid, gallic acid, syringic acid, benzoic acid, cinnamic acid, ferulic acids, myricetin, chlorogenic acid, caffeic acid, hesperetin, coumaric acid, isoramnetin, chrysin, quercetin, galangin, luteolin and kaempferol [19,27,44,45]. While some of these bioactive compounds such as alangin, kaempferol, quercetin, isorhamnetin and luteolin are found in most honey samples, others such as hesperetin and naringenin are found in few honey varieties [45]. Among some Malaysian honey samples investigated, catechin was found to be a common flavonoid [33]. By and large, the avalanche of data on the in vitro antioxidant activities of honey indicate that honey is not only an antioxidant but also a rich source of antioxidants. The molecular structures of some of the biologically active ingredients or constituents including organic acids, flavonoids and phenolic compounds in honey which may contribute to the antioxidant effect of honey are presented in Figure 2a and b [23,46].

Figure 2

Molecular structures of some of the organic acids, flavonoids and phenolic compounds present in honey.

3. Honey: A Novel Antioxidant–Evidence from <italic>in Vivo</italic> Studies

Available data indicate that honey, like other antioxidant agents, does protect against damage or injury. This protective effect of honey is partly mediated via amelioration of oxidative stress in tissues such as GIT, liver, kidney, pancreas, eye, plasma, red blood cells and reproductive organs [11,12,13,14,15,19]. Therefore, the in vivo antioxidant effect of honey will be discussed in regard to its ability to ameliorate oxidative stress in various cells, tissues, organs or body fluids.

3.1. GIT

Evidence indicates that in diseased conditions such as diabetes mellitus, the GIT is susceptible to oxidative stress, which may impair the brush border membrane (BBM) fluidity [47]. The intestinal uptake of substances, molecules or mineral ions is also known to be modulated or influenced by the redox state of the transporter [48]. These transporters can be regulated rapidly through alteration of their trafficking or affinities in response to oxidative stress [49]. The beneficial effect of GSH, an antioxidant, on these transporters has been demonstrated [49]. It is suggested that such modification of redox or oxidative state might influence the bioavailability of essential macronutrients and drugs [49]. Antioxidant vitamin E was reported to increase the activities of CAT and SOD and reduce lipid peroxidation and protein oxidation in small intestine of diabetic rats [50]. At the moment, there is no evidence to suggest that honey exerts an antioxidant effect in the intestine. However, considering the reported antioxidant effect of honey in different cells or tissues such as pancreas, serum, kidney and liver [15,20,42,44], it is possible that honey might also ameliorate intestinal oxidative stress. Hence, it may not be a surprise that co-administration of hypoglycemic agents and honey further improves glycemic control in diabetic rats [51]. This might be due to modification of intestinal redox or oxidative state which influences the bioavailability of hypoglycemic drugs [49].

Available evidence indicates that honey exerts gastroprotective effect in rodents administered indomethacin, ethanol, aspirin or ammonia [11,52,53,54]. Although the sugars such as fructose, glucose, sucrose and maltose present in honey may play a role in its gastroprotective effect [11,53], there is a possibility that the antioxidant effect of honey may also contribute to its gastroprotective effect. This assertion is based on the evidence which indicates that increased mucosal lipid peroxide and reduced GSH levels exacerbate gastric hemorrhagic ulcer in diabetic rats [55]. Another study also reported increased lipid peroxidation and impaired antioxidant enzymes (increased SOD and decreased CAT activities) in gastric mucosa of rats with cold restraint stress-induced gastric ulceration [56]. A similar increase in oxidative stress level was also demonstrated in patients with peptic ulceration and gastric carcinoma [56]. Additional evidence in support of the role of antioxidant effect of honey in mediating its gastroprotective effect is provided by Kim [57]. The author found that oxidative stress is one of the mechanisms by which Helicobacter pylori induces gastric injury [57]. Interestingly, honey also inhibits the growth of Helicobacter pylori, which causes gastric and duodenal ulcers [58,59]. Considering the prolonged gastric ulcer healing, the prevalence of silent gastric ulcer or erosions and the highly oxidative milieu in diabetes mellitus [60,61,62], the antioxidant-mediated gastroprotective effect of honey might be beneficial in diabetes mellitus. Honey might also be valuable in ulcerative colitis [63]. In trinitrobenzosulphonic acid (TNBS)-induced ulcerative colitis model in rats, honey combined with an antibiotic (sulfasalazine) enhanced antioxidant defense system and reduced oxidative damage and colonic inflammation [63]. Similarly, in rats with chemically (TNBS)-induced colitis, honey supplementation significantly reduced the colonic mucosal malondialdehyde (MDA) content [64]. In a nutshell, amelioration of oxidative stress as a result of honey administration might restore impaired intestinal brush border membrane (BBM) fluidity and redox or oxidative state. This might modify or modulate the bioavailability of vital macronutrients and drugs. This antioxidant effect in the GIT might also contribute to the gastroprotective effect of honey.

3.2. Livers

The liver plays an important role in many metabolic processes such as glycemic control, detoxification of xenobiotics, synthesis of lipoproteins, hormones and enzymes [65]. In diabetes mellitus, the liver is associated with abnormalities such as elevations in serum aspartate aminotransferase, alkaline phosphatase and alanine aminotransferase [66]. Available evidence suggests that the liver is susceptible to oxidative stress and damage; and the beneficial effect of antioxidants on hepatic oxidative stress has been documented [67,68]. In the liver of young and middle-aged rats, honey supplementation was reported to restore activities of CAT and GPx [69]. In male BALB/c mice administered trichlorfon, oral supplementation with pine honey restored the activities of hepatic GPx (significantly) and SOD and CAT (moderately) and reduced hepatic damage [45]. Similar hepatoprotective effect of honey was also reported in STZ-induced diabetic rats [70] and sheep administered carbon tetrachloride (CCl₄) [71]. In rats with obstructive jaundice, usually associated with increased hepatic ROS formation, oxidative stress and inflammation [72,73], honey supplementation significantly reduced the levels of MDA and increased GSH content in the liver [74]. The amelioration of oxidative stress, as a result of honey administration, was accompanied by significant reductions in the size of enlarged hepatocytes and edema, restoration of bile canaliculi dilatation and reduced number of apoptotic cells [74]. Similar hepatoprotective effect of honey was also reported in rats with obstruction of the common bile duct [75]. In rats with N-ethylmaleimide (NEM)-induced liver injury, honey supplementation significantly restored the levels of hepatic glutathione, ameliorated the (NEM)-induced congestion and mononuclear cell infiltration in the liver [76]. Supplementation with honey and ginseng was reported to protect against CCl₄-induced hepatotoxicity in rats by reducing lipid peroxidation and enhancing antioxidant capacity [77]. These findings, generally, suggest that amelioration of oxidative stress in the liver may contribute to the hepatoprotective effect of honey.

3.3. Pancreas

The pancreas plays an important role in glucose homeostasis [65]. Evidence indicates that the efficiency of pancreas to secrete insulin declines in diabetes mellitus, resulting in deterioration of glycemic control [78]. The role of oxidative stress is implicated in the decline of pancreatic function in diabetes mellitus [78,79]. The pancreatic β-cells are highly vulnerable to oxidative stress as a result of their intrinsically low expressions and activities of free radical scavenging enzymes [80]. The beneficial effect of antioxidants in protecting the pancreas against oxidative stress and damage is well documented [81]. We have shown that honey has a potential to protect pancreas against oxidative stress and damage. Honey supplementation significantly reduced elevated levels of MDA and restored the activities of SOD and CAT in pancreas of diabetic rats [82]. We have also investigated and compared the effect of glibenclamide alone with that of glibenclamide and honey on oxidative stress in pancreas of diabetic rats [83]. The data revealed that glibenclamide did not ameliorate oxidative stress in the pancreas of diabetic rats. In contrast, the pancreas of diabetic rats treated with the combination of glibenclamide and honey had increased CAT activity and restored the elevated GPx activity and levels of MDA [83]. In another related study, we found that the combination of glibenclamide and metformin ameliorated oxidative stress only partially [84]. This was evidenced by the attenuation of GPx activity only while no significant effect on other antioxidant enzymes and lipid peroxidation was observed in the pancreas of diabetic rats [84]. In contrast, the combination of glibenclamide, metformin and honey significantly increased CAT activity while GPx activity was down-regulated. The combination with honey also considerably prevented lipid peroxidative damage [84]. These data clearly suggest that the combination of hypoglycemic agents with honey markedly restores antioxidant enzymes, ameliorates oxidative stress and protects the pancreas against oxidative damage.

3.4. Kidney

The kidney plays an important role in the excretion and regulation of osmolytes, especially in diabetes mellitus [85]. In hypertension, the kidney is an important regulator of many mechanisms involved in the regulation of blood pressure [85]. Thus, any damage to this organ will exacerbate these two diseases. Available evidence indicates that the kidney is a major target of oxidative stress in both diabetes mellitus and hypertension [85,86].

3.4.1. Diabetes Mellitus

Without adequate treatment, diabetic patients are more likely to develop diabetic nephropathy and overt renal failure [85]. In view of the evidence that implicates a role of oxidative stress in the complications of diabetes mellitus [86], a number of studies have investigated the potential role of antioxidants in protecting the kidney against oxidative damage [87]. Our studies have shown that honey ameliorates renal oxidative stress. Honey administration to diabetic rats significantly increased total antioxidant status (TAS), activities of glutathione S-transferase (GST), glutathione reductase (GR), CAT and GPx [15]. It also restored SOD activity while it reduced the levels of lipid peroxidation. This antioxidant effect of honey was accompanied by improvements in renal morphology as evidenced by reduced mesangial matrix expansion and thickening of glomerular basement membrane in the honey-treated diabetic rats [15]. The study further revealed that the antioxidant effect of the lowest dose of honey, 0.2 g/kg body weight (despite its lower hypoglycemic effect), was comparable to that of the higher doses (1.2 or 2.4 g/kg body weight) [15]. This suggests that the antioxidant effect of honey is not dependent on its hypoglycemic effect. Other studies have also demonstrated the antioxidant effect of honey in kidney of rats with diabetes [88] or without diabetes [89].

We have also investigated and compared the effects of honey, glibenclamide, metformin, glibenclamide and metformin, as well as their combinations with honey on oxidative stress in kidney of diabetic rats [90,91]. Our results indicated that the activities of CAT and GR as well as TAS and reduced glutathione (GSH) in diabetic rats treated with metformin and/or glibenclamide remained similar to those of diabetic control rats [91]. In contrast, metformin or glibenclamide combined with honey significantly increased the activities of CAT and GR and also TAS and GSH in the kidney of diabetic rats [91]. Other authors have also shown that in rats administered CCl₄, honey supplementation prevented CCl₄-induced nephrotoxicity via enhanced antioxidant capacity and reduced lipid peroxidation [77]. In summary, these results suggest that the combination of hypoglycemic drugs, glibenclamide and/or metformin with honey in diabetic rats ameliorates renal oxidative stress better than either agent administered alone [90,91].

3.4.2. Hypertension

The role of oxidative stress in hypertension is a subject of much research interest. Oxidative stress is implicated in the pathogenesis of hypertension [92], while some evidence also indicates that hypertension generates oxidative stress [93]. These lines of evidence support a role of oxidative stress as an important determinant in the imbalance between vasoconstrictor and vasodilator mechanisms [92,93,94]. The beneficial effects of antioxidants in ameliorating oxidative stress and suppressing or reducing elevated blood pressure in experimental and clinical studies further corroborate the role of oxidative stress in hypertension [95]. In a recent study, we reported that honey supplementation in spontaneously hypertensive rats (SHR) restored the elevated antioxidant defenses (GST, TAS and CAT) in kidney of SHR [94]. Honey administration also prevented the formation of MDA in the kidney of SHR [94]. The amelioration of oxidative stress was accompanied by suppressed elevations in blood pressure in SHR [94].

The combination of diabetes mellitus and hypertension is associated with increased cardiovascular risk factors [96,97]. Besides other factors, evidence suggests that diabetes mellitus may exacerbate hypertension via increased oxidative stress [98]. We recently investigated the effect of honey on oxidative stress in kidney of rats with both diabetes mellitus and hypertension [99,100]. We found that honey supplementation significantly increased intracellular GSH, GSH/GSSG (oxidized glutathione) ratio, TAS and activities of GPx and GR in kidney of diabetic SHR [99,100]. The study also revealed that the antioxidant effect of honey resulted in further reductions in blood pressure of diabetic SHR but not of diabetic WKY [99,100]. These findings reveal that similar to the antioxidant effect of honey in the diabetic kidney, honey supplementation also ameliorates oxidative stress in the kidney of hypertensive rats. This antioxidant effect of honey results in suppression of blood pressure. Honey also exerts its antioxidant effect in kidney of rats with both diabetes mellitus and hypertension. We and others reported recently that reduced or impaired Nrf2 activity or expression contributes to increased susceptibility of kidney to oxidative stress in rats with chronic renal failure [101] or hypertension [94,102]. Data from our laboratory indicate honey may ameliorate oxidative stress via up-regulation of Nrf2 activity or expression [94,102]. Nrf2 is a transcription factor released from its repressor (Keap1) under oxidative or xenobiotic stress [103]. It translocates from the cytoplasm to the nucleus and binds to the antioxidant response element (ARE) in the promoter region of cytoprotective genes, resulting in their transcription [103]. The transcription of these genes subsequently induces free radical scavenging enzymes and other detoxifying enzymes which swiftly neutralize, detoxify and eliminate the oxidants or xenobiotics [103].

3.5. Plasma/Serum

In diabetes mellitus, the levels of plasma glucose, fructosamine and glycosylated hemoglobin are used as indicators of glycemic control [104]. Elevated plasma glucose generates ROS which cause oxidative stress [86]. Oxidative stress is implicated in the cellular dysfunction and complications of diabetes [86]. Evidence indicates that agents (such as pyridoxine, pyridoxamine and gliclazide) that scavenge or inhibit ROS formation enhance antioxidant defenses (SOD, thiols, TAS), reduce oxidative stress markers (8-isoprostanes and MDA) and protein glycosylation in diabetes [105,106]. In some studies, amelioration of oxidative stress using antioxidants was accompanied by reduced hyperglycemia [81]. However, some studies found no such effect [67]. Antioxidants have been shown to reduce the elevated levels of plasma glucose and glycosylated hemoglobin [81]. In STZ-induced diabetic Sprague-Dawley rats, honey supplementation reduced hyperglycemia [15,88]. A similar hypoglycemic effect of honey was also reported in alloxan-induced diabetic rats [107], STZ-induced diabetic Wistar-Kyoto rats [99] and STZ-induced diabetic SHR [99]. In those studies, similar to what was reported for other antioxidants, hypoglycemic effect of honey was accompanied by amelioration of oxidative stress [15,88,99].

Besides the hypoglycemic effect of honey, we also found in another study that honey supplementation reduced fructosamine concentrations in STZ-induced diabetic rats [51]. Fructosamine is a stable compound formed from the reaction of a carbonyl group of glucose with an amino group of protein [108]. It can be formed from serum proteins such as albumin to produce glycated serum protein. In a highly oxidative environment (such as in diabetes), fructosamine can form advanced glycation end products (AGEs), which is implicated in diabetic complications [108]. The ability of honey to reduce fructosamine may be attributed to its antioxidant effect. Honey has been shown to increase serum antioxidant capacity [103]. Compelling evidence indicates that glycation and oxidative reactions (or their products) are mutually dependent and strongly correlate [108,110]. A number of antioxidants such as α-lipoic acid, taurine, vitamins C and E have been shown to reduce fructosamine and glycosylated hemoglobin by inhibiting the formation of MDA, protein glycation and advanced glycation end products [108,111,112]. Another study reported reduced glycosylated hemoglobin in non-diabetic rats after chronic (52 weeks) honey supplementation [113]. A similar beneficial effect of honey was reported in patients with impaired lipid metabolism [114,115,116]. In diabetes, the antioxidant effect of honey may also be beneficial in lipid metabolism [51,113,114,115,116] (e.g., in inhibiting or preventing the oxidation of low density lipoprotein) [105]. A study that investigated the protective effect of honey and Nigella grains against methylnitrosourea-induced oxidative stress and carcinogenesis indicated that Nigella sativa grains reduced the elevated levels of MDA and nitric oxide (NO) in serum and produced a protective effect of 80%. On the other hand, combination of honey and Nigella sativa abolished the increases in MDA and NO and exerted a protective effect of 100% against MNU-induced oxidative stress and carcinogenesis [117]. Other studies have also demonstrated the antioxidant effect of honey in serum as evidenced by the increased plasma NO metabolites in healthy sheep [118] and the increased GPx activity and NO in the serum of alloxan-induced diabetic rats [119].

3.6. Reproductive Organs

The exposure to cigarette smoke (CS) causes apoptosis and damage in the testis [120]. Evidence implicates the role of oxidative stress in CS-induced testicular damage [121]. A number of studies have demonstrated the beneficial effects of antioxidants in preventing or ameliorating testicular damage in rodents [122]. A study investigated the effect of honey in the testis of rats exposed to CS [123]. It was found that honey supplementation for 13 weeks markedly reduced the level of lipid peroxidation [123]. Honey administration also increased the reduced TAS and restored the activities of SOD, GPx and CAT. This antioxidant effect of honey was associated with amelioration of testicular damage as evidenced by higher Leydig cell count, reduced percentage of tubules with germ cell loss, larger seminiferous tubules diameter and epithelial height [123]. These data suggest that honey may protect or ameliorate CS-induced testicular damage in rats via its antioxidant effect. The authors in one of their previous studies also reported that honey supplementation in normal rats improved spermatogenesis [13]. A recent study also demonstrated the beneficial effects of honey on sperm motility and morphology in rats [124]. A study by Abdul-Ghani and colleagues also indicated that honey supplementation in rats caused increased epididymal sperm count and improved the activity of testicular marker enzymes for spermatogenesis, as evidenced by increased sorbitol dehydrogenase and reduced lactate dehydrogenase [125]. Available data in ovariectomised female rats also suggest that honey may produce beneficial effects in female reproductive organs [14]. A similar beneficial effect of honey on oxidative stress was also reported in human subjects [126]. A study investigated the effects of 8-week honey supplementation on seminal plasma cytokines, oxidative stress and antioxidants in male road cyclists during intensive cycling training [126]. The study found that honey supplementation significantly increased the concentrations of seminal SOD, CAT and TAS. This antioxidant effect of honey was also associated with lower elevations in the seminal IL-1beta, IL-6, IL-8, TNF-alpha, ROS and MDA levels [126].

3.7. Eye

Visual impairment caused by alkali burns of the corneal and conjunctival surface is considered one of the most devastating injuries to the eye [127,128]. These chemical burns-induced eye injuries are accompanied by increased oxidative stress [127,128]. The beneficial effects of antioxidants in the treatment of these eye injuries have been reported [127,128]. A study investigated and compared the antioxidant effects of honey and conventional treatment in alkali injury on the eyes of New Zealand White rabbits [129]. The study did not find any significant difference in TAS and MDA levels in aqueous humour, vitreous humour and serum of rabbits treated with honey and conventional treatment [129]. The lack of significant effect of honey on oxidative stress parameters might be a result of the short duration of the study (7 days). Other possible explanations include non-inclusion of control and small sample size. Therefore, considering the previous data on the beneficial effects of antioxidants in chemical burns-induced eye injuries in animals [127,128], together with the limitations of this recent study [129], it is premature to conclude that honey is not beneficial in the treatment of chemical burns-induced eye injuries in animals. This is in view of the fact that honey has been shown to be beneficial in other eye diseased conditions such as in human patients with dry eye syndrome [130] or endophthalmitis [131].

3.8. Other Antioxidant Effects of Honey

In the erythrocytes of young and middle-aged rats, honey supplementation was reported to restore activities of CAT and GPx [69]. Evidence also indicates that honey has a potential to ameliorate oxidative stress in the brain and heart [39]. In a cultured endothelial cell line, Beretta and colleagues used cumene hydroperoxide to generate free radicals and oxidative stress [42]. The authors found that honey produced strong scavenging activity against lipophilic cumoxyl and cumoperoxyl radicals, reduced intracellular ROS generation and restored intracellular GSH [42]. The authors also reported that honey considerably inhibited oxidation of cell membrane and prevented cellular damage. The study further revealed that the antioxidant effect of honey was due to its phenolic acids and flavonoids [42]. The antioxidant effect of honey might also contribute to other beneficial effects of honey such as reduced weight gain and improved lipid metabolism in rats or human subjects administered honey [132,133,134].

3.9. Effects of Honey on Inflammation

Oxidative stress and inflammation are frequent manifestations and play an important role in the etiology of many diseases and disorders [74,76,135]. Evidence indicates that they are intimately interrelated as each can cause the other [74,76,135]. In rats with inflammatory bowel disease, intra-rectal honey administration significantly reduced myeloperoxidase (MPO) activity [64]. This was associated with lower levels of colonic MDA with no change in NO content [64]. A recent study that investigated the effects of honey and its extracts in rat models of inflammation reported that honey and its extracts inhibited NO and prostaglandin E(2) production [136]. The authors also found that honey and its extracts reduced edema and pain in inflammatory tissues. The inhibition of edema and pain was found to correlate with the inhibition of nitric oxide and prostaglandin E(2) [136]. Another study investigated the effects of various doses of honey on acute and chronic inflammations in rats using carrageenan, cotton pellet and formaldehyde methods and NO production by administering N^G-nitro-L-arginine methyl ester (L-NAME) and L-arginine [137]. Honey supplementation was found to reduce the paw size, the granuloma weight and the arthritis in the carrageenan, the cotton pellet and formaldehyde methods, respectively [137]. Additional evidence in support of the anti-inflammatory effect of honey was demonstrated by inhibition of paw oedema by L-NAME and the loss of anti-inflammatory effect of honey following the administration of L-arginine [137]. These data indicate that honey can exert an anti-inflammatory effect via inhibition of NO and prostaglandin E(2) production and release [137]. This antioxidant effect may contribute to its anti-inflammatory effect. Table 1 summarizes the antioxidant effect of honey in different tissues.

molecules-17-04400-t001_Table 1

Table 1

Summary of the antioxidant effects of honey in different tissues.

Tissue/Study design	Oxidative stress status		Ref.
Tissue/Study design	Control	Honey	Ref.
GIT
Rats with TNBS-induced colitis	↑ MDA; ↑ MPO; ↓ SOD; ↓ CAT; ↓ GPx and ↓ GSH	↓ MDA; ↓ MPO; ↑ SOD; ↑ CAT; ↑ GPx and ↑ GSH	63,64
Liver
Rats or mice with trichlorfon-, NEM- or CCl₄-induced liver injury or obstructive jaundice	↑ GPx; ↑ CAT; ↓ GSH; ↑ MDA and TAC	↓ GPx; ↓ CAT; ↑ GSH; ↓ MDA and TAC	44,69,74,76,77
Pancreas
Rats with STZ-induced diabetes	↑ SOD; ↑ GPx; ↓ CAT and ↑ MDA	↓ SOD; ↑ CAT; ↓ GPx and ↓ MDA	82,83,84
Kidney
Rats with STZ-induced diabetes (diabetic SD) or with CCl₄-induced nephrotoxicity	↑ MDA; ↓ TAS; ↓ CAT; ↓ GPx; ↓ GST; ↓ GR; ↑ SOD and ↓ GSH	↓ MDA; ↑TAS; ↑ CAT; ↑ GPx; ↑ GST; ↑ GR; ↓ SOD and ↑ GSH	15,77,88,90,91
Rats with hypertension (SHR)	↑ MDA; ↑ GST; ↑ TAS and ↑ CAT	↓ MDA; ↓ GST; ↓ TAS and ↓ CAT	94,102
Rats with diabetes (diabetic WKY)	↔ MDA; ↔ CAT; ↑ GPx; ↔ GR; ↓ TAS and ↔ GSH/GSSG	↔ MDA; ↔ CAT; ↔ TAS; ↓ GPx; ↓ GR and ↑ GSH/GSSG	99,100
Rats with both diabetes and hypertension (diabetic SHR)	↔ MDA; ↓ CAT; ↓ GPx; ↓ GR; ↓ TAS; ↔ GSH and ↔ GSH/GSSG	↔ MDA; ↔ CAT; ↑ GPx; ↑ GR; ↑ TAS; ↑ GSH and ↑ GSH/GSSG	99,100
Plasma/serum
MNU-induced oxidative stress	↑ MDA and ↑ NO	↓ MDA and ↑ NO	117
Alloxan- or STZ-induced diabetic rats or non-diabetic rats	↓ GPx; ↓ NO and ↑ formation of glycated products (fructosamine and glycated hemoglobin)	↑ GPx; ↑ NO; ↑ TAS and ↓glycated products (fructosamine and glycated hemoglobin)	44,51,69,119
Reproductive organs
Testis of rats exposed to cigarette smoke	↑ MDA; ↓ TAS; ↓ SOD; ↓ CAT and ↑ GPx	↓ MDA; ↓ GPx; ↑ TAS; ↑ SOD; ↑ CAT and ↑ GSH	123
Seminal oxidative stress in male cyclists undergoing intensive cycling training	↓ TAS; ↓ SOD and ↓ CAT	↓ MDA; ↓ ROS; ↑ SOD, ↑ CAT and ↑ TAS	126
Other tissues or cells
Whole blood and erythrocytes of young (2 months) and middle-aged (9 months) rats	Whole blood: ↑ DNA damage; Erythrocytes: ↓ GPx and ↑ CAT	↓ DNA damage ↑ GPx and ↓ CAT	44,69
In a cultured endothelial cell line	↑ ROS and ↓ GSH	↓ ROS and ↑ GSH	42
In inflammation	↑ NO and ↑ prostaglandin E(2)	↓ NO; ↓ prostaglandin E(2) and ↓ inflammation	136,137

TNBS, trinitrobenzene sulfonic acid; MPO, myeloperoxidase; NEM, N-ethylmaleimide; TAC or TAS, total antioxidant capacity or status; 8-IP, 8-isoprostane; SOD, superoxide dismutase; CAT, catalase; GPx, glutathione peroxidase; GR, glutathione reductase; glutathione S-transferase; NO, nitric oxide; ROS, reactive oxygen species; GSH, reduced glutathione; GSSG, oxidized glutathione; MDA, malondialdehyde; ↑ = increased/enhanced; ↓ = reduced/attenuated; ↔ = no significant effect.

4. Could Honey Be a Better Antioxidant than Some of the Commonly Available Antioxidants

The beneficial effects of different antioxidants, especially vitamins C and E, are well documented in various disease models in both rodents and humans [138,139,140,141,142]. However, some demerits have also been reported for some of these antioxidants or vitamins [143]. Although they are potent, their mechanisms of antioxidant action are a bit complex in the sense that their antioxidant action does not end with scavenging or elimination of free radicals [143]. Instead, these vitamins themselves become pro-oxidants that may require antioxidants for their regeneration into the active or antioxidant form [144,145]. This, therefore, suggests that supplementation with such antioxidants especially at high doses may perturb the delicate physiological balance among the antioxidants [142,144,145]. In diseases characterized by oxidative stress, such an imbalance in endogenous antioxidant defenses caused by exogenously administered or ingested antioxidants, instead of ameliorate may further exacerbate oxidative stress or may do more harm than good [142,146]. In some cases, these vitamins exacerbated diseases and increased mortality [147]. Most of those trials used vitamins C and E as antioxidants of first choice and were characterized by undefined selection of doses. For instance, there are reports that large doses of dietary α-tocopherol supplementation interfere with or displace γ-tocopherol in the plasma and tissues [143,148] or may enhance formation of tumor [144,149]. Antioxidant (β-carotene) supplementation in smokers was also reported to exacerbate the risk of cancer [147]. Although both α-tocopherol and γ-tocopherol protect against peroxynitrite-induced lipid oxidation, evidence indicates that γ-tocopherol is essential for efficient removal of peroxynitrite-derived nitrating species [145,150]. Some evidence also suggests that γ-tocopherol is a better inhibitor of nitrogen dioxide-mediated nitrosation than α-tocopherol [151].

In a nutshell, as a result of dearth of data, it remains unclear if honey will be more effective or efficacious than vitamins C or E in ameliorating oxidative stress. However, honey administered at therapeutic doses is likely to be devoid of pro-oxidant properties often associated with vitamins C and E. Another advantage of honey over vitamins C and E is the fact that honey comprises several bioactive constituents. Many of these constituents may produce synergistic antioxidant effects. Besides, unlike vitamin C or E which requires the other for regeneration into the active form [138,139], this may be unnecessary with the use of honey. If any of the antioxidant constituents in honey exhibits pro-oxidant properties, there would be sufficient antioxidants for its regeneration. Available evidence suggests that honey may ameliorate oxidative stress by scavenging both free radicals such as OONO⁻, O₂^•−[38] and non-free radicals such as NO [64]. Recently, we found that honey ameliorates oxidative stress by up-regulating Nrf2 moderately, an important intracellular transcription factor [88]. Evidence also suggests that honey may reduce inflammation as evidenced by the inhibition of NO and prostaglandin E(2) production [64,136]. This is important because both oxidative stress and inflammation are interrelated [135]. Besides, evidence implicates the role of oxidative stress and inflammation in the pathogenesis and complications of many chronic diseases such as diabetes mellitus and hypertension [152]. Therefore, considering the antioxidant and anti-inflammatory effects of honey [15,74,82,90,91,94,99,100,136,137], the use of honey might be more beneficial or advantageous than some of the previously investigated antioxidants such as vitamins C and E.

5. Conclusions

The prevalence of chronic diseases such as diabetes mellitus, hypertension, atherosclerosis and cancer in the population is increasing. This has also resulted in increased mortality resulting from these diseases. The evidence which implicates the role of oxidative stress in the pathogenesis or complications of these diseases suggests that antioxidants may be beneficial. The data from large scale clinical trials have not been impressive and a number of reasons have been posited. One is the choice of certain antioxidants over the others – primarily, the use of vitamins C and E only in most of the trials. Honey is a natural product with many health benefits. The data presented in this paper indicate that honey may or can ameliorate oxidative stress in the GIT, liver, pancreas, kidney, testis and plasma. Besides, the data also indicate that the combination of conventional therapy, e.g., antidiabetic drugs, with honey produces synergistic antioxidant effect in the pancreas, kidney and plasma of diabetic rats. Honey, administered alone or in combination with conventional therapy, might be a novel antioxidant in the management of many diseases associated with oxidative stress. There is no doubt that studies investigating the effect of honey on oxidative stress are at a relatively early stage. However, a closer look at the presented data reveals that clinical studies that investigated the antioxidant effect of honey are limited. Therefore, it will be worthwhile to investigate some of these data in clinical studies to confirm if this antioxidant effect of honey can be extrapolated to humans. Together with its anti-inflammatory effect, the use of honey (especially in combination with conventional therapy) in the management of chronic diseases associated with oxidative stress holds much promise.

Acknowledgments

The studies on the effects of Malaysian tualang honey were financially supported by Universiti Sains Malaysia.

Conflict of Interest

The authors declare that they have no personal or financial conflict of interest.

References and Notes 1.

Doll

Chronic and degenerative disease: Major causes of morbidity and death

Am. J. Clin. Nutr. 1995 62 1301S 1305S

7495224

Albright

Biological and social exposures in youth set the stage for premature chronic diseases

J. Am. Diet Assoc. 2008 108 1843 1845

10.1016/j.jada.2008.09.017

18954573

Shibata

Kobayashi

The role for oxidative stress in neurodegenerative diseases

Brain Nerve 2008 60 157 170

18306664

Kadenbach

Ramzan

Vogt

Degenerative diseases, oxidative stress and cytochrome c oxidase function

Trends Mol. Med. 2009 15 139 147

10.1016/j.molmed.2009.02.004

19303362

Sies

Oxidative stress: Introduction

Oxidative Stress: Oxidants and Antioxidants Academic Press

London, UK

1991 6.

Halliwell

Gutteridge

J.M.C.

Free Radicals in Biology and Medicine Clarendon Press

Oxford, UK

2007 7.

Halliwell

Free radicals and antioxidants-quo vadis?

Trends Pharmacol. Sci. 2011 32 125 130

10.1016/j.tips.2010.12.002

Uttara

Singh

A.V.

Zamboni

Mahajan

R.T.

Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options

Curr. Neuropharmacol. 2009 7 65 74

10.2174/157015909787602823

19721819

Ienco

E.C.

LoGerfo

Carlesi

Orsucci

Ricci

Mancuso

Siciliano

Oxidative stress treatment for clinical trials in neurodegenerative diseases

J. Alzheimers Dis. 2011 24 111 126

21422516

10.

Erejuwa

O.O.

Management of diabetes mellitus: Could simultaneous targeting of hyperglycemia and oxidative stress be a better panacea?

Int. J. Mol. Sci. 2012 13 2965 2972

10.3390/ijms13032965

11.

Gharzouli

Amira

Gharzouli

Khennouf

Gastroprotective effects of honey and glucose-fructose-sucrose-maltose mixture against ethanol-, indomethacin- and acidified aspirin-induced lesions in the rat

Exp. Toxicol. Pathol. 2002 54 217 221

10.1078/0940-2993-00255

12484559

12.

Al-Waili

N.S.

Saloom

K.Y.

Al-Waili

T.N.

Al-Waili

A.N.

Akmal

Al-Waili

F.S.

Al-Waili

H.N.

Influence of various diet regimens on deterioration of hepatic function and hematological parameters following carbon tetrachloride: A potential protective role of natural honey

Nat. Prod. Res. 2006 20 1258 1264

10.1080/14786410600906475

17127519

13.

Mohamed

Sulaiman

S.A.

Jaafar

Sirajudeen

K.N.

Effect of different doses of Malaysian honey on reproductive parameters in adult male rats

Andrologia 2011

10.1111/j.1439-0272.2010.01159.x

14.

Zaid

S.S.

Sulaiman

S.A.

Sirajudeen

K.N.

Othman

N.H.

The effects of Tualang honey on female reproductive organs, tibia bone and hormonal profile in ovariectomised rats-animal model for menopause

BMC Complement. Altern. Med. 2011 10 82 15.

Erejuwa

O.O.

Gurtu

Sulaiman

S.A.

Ab Wahab

M.S.

Sirajudeen

K.N.

Salleh

M.S.

Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats

Int. J. Vitam. Nutr. Res. 2010 80 74 82

10.1024/0300-9831/a000008

20533247

16.

Al-Waili

Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: Their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate

Eur. J. Med. Res. 2003 8 295 303

12911866

17.

Tan

H.T.

Rahman

R.A.

Gan

S.H.

Halim

A.S.

Hassan

S.A.

Sulaiman

S.A.

Kirnpal-Kaur

The antibacterial properties of Malaysian tualang honey against wound and enteric microorganisms in comparison to manuka honey

BMC Complement. Altern. Med. 2009 9 34

10.1186/1472-6882-9-34

19754926

18.

Koc

A.N.

Silici

Kasap

Hormet-Oz

H.T.

Mavus-Buldu

Ercal

B.D.

Antifungal activity of the honeybee products against Candida spp. and Trichosporon spp.

J. Med. Food. 2011 14 128 134

10.1089/jmf.2009.0296

19.

Kassim

Achoui

Mustafa

M.R.

Mohd

M.A.

Yusoff

K.M.

Ellagic acid, phenolic acids and flavonoids in Malaysian honey extracts demonstrate in vitro anti-inflammatory activity

Nutr. Res. 2010 30 650 659

10.1016/j.nutres.2010.08.008

20934607

20.

Bogdanov

Jurendic

Sieber

Gallmann

Honey for nutrition and health: A review

J. Am. Coll. Nutr. 2008 27 677 689

19155427

21.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Fructose might contribute to the hypoglycemic effect of honey

Molecules 2012 17 1900 1915

10.3390/molecules17021900

22337138

22.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Oligosaccharides might contribute to the antidiabetic effect of honey: A review of the literature

Molecules 2012 17 248 266 23.

Chemblink

(accessed on 11 April 2012)

Available online:http://www.chemblink.com 24.

ScienceAid

(accessed on 11 April 2012)

Available online:http://scienceaid.co.uk/biology/-biochemistry/carbohydrates.html 25.

File:Isomaltose.svg

(accessed on 11 April 2012)

Available online:https://commons.wikimedia.org/wiki/File:Isomaltose.svg# 26.

Gheldof

Wang

X.H.

Engeseth

N.J.

Identification and quantification of antioxidant components of honeys from various floral sources

J. Agric. Food Chem. 2002 50 5870 5877

10.1021/jf0256135

12358452

27.

Hussein

S.Z.

Yusoff

K.M.

Makpol

Yusof

Y.A.

Antioxidant capacities and total phenolic contents increase with gamma irradiation in two types of Malaysian honey

Molecules 2011 16 6378 6395

21796076

28.

Akbulut

Ozcan

M.M.

Coklar

Evaluation of antioxidant activity, phenolic, mineral contents and some physicochemical properties of several pine honeys collected from Western Anatolia

Int. J. Food Sci. Nutr. 2009 60 577 589

10.3109/09637480801892486

19817637

29.

Al-Hindi

R.R.

Bin-Masalam

M.S.

El-Shahawi

M.S.

Antioxidant and antibacterial characteristics of phenolic extracts of locally produced honey in Saudi Arabia

Int. J. Food Sci. Nutr. 2011 62 513 517

10.3109/09637486.2010.550276

21391794

30.

Rodríguez-Malaver

A.J.

Rasmussen

Gutiérrez

M.G.

Gil

Nieves

Vit

Properties of honey from ten species of Peruvian stingless bees

Nat. Prod. Commun. 2009 4 1221 1226

19831033

31.

Oddo

L.P.

Heard

T.A.

Rodriguez-Malaver

Perez

R.A.

Fernandez-Muino

Sancho

M.T.

Sesta

Lusco

Vit

Composition and antioxidant activity of Trigona carbonaria honey from Australia

J. Med. Food. 2008 11 789 794

10.1089/jmf.2007.0724

19012514

32.

Mohamed

Sirajudeen

Swamy

Yaacob

N.S.

Sulaiman

S.A.

Studies on the antioxidant properties of Tualang honey of Malaysia

Afr. J. Tradit. Complement. Altern. Med. 2009 7 59 63

21304614

33.

Khalil

M.I.

Alam

Moniruzzaman

Sulaiman

S.A.

Gan

S.H.

Phenolic acid composition and antioxidant properties of Malaysian honeys

J. Food Sci. 2011 76 C921 C928

10.1111/j.1750-3841.2011.02282.x

22417491

34.

Kishore

R.K.

Halim

A.S.

Syazana

M.S.

Sirajudeen

K.N.

Tualang honey has higher phenolic content and greater radical scavenging activity compared with other honey sources

Nutr. Res. 2011 31 322 325

10.1016/j.nutres.2011.03.001

21530807

35.

van den Berg

A.J.

van den Worm

van Ufford

H.C.

Halkes

S.B.

Hoekstra

M.J.

Beukelman

C.J.

An in vitro examination of the antioxidant and anti-inflammatory properties of buckwheat honey

J. Wound Care 2008 17 172 178

18494436

36.

Jerkovic

Marijanovic

Oak (Quercus frainetto Ten.) honeydew honey--approach to screening of volatile organic composition and antioxidant capacity (DPPH and FRAP assay)

Molecules 2010 15 3744 3756

10.3390/molecules15053744

37.

Pérez

R.A.

Iglesias

M.T.

Pueyo

Gonzalez

de Lorenzo

Amino acid composition and antioxidant capacity of Spanish honeys

J. Agric. Food Chem. 2007 55 360 365

10.1021/jf062055b

17227066

38.

Estevinho

Pereira

A.P.

Moreira

Dias

L.G.

Pereira

Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey

Food Chem. Toxicol. 2008 46 3774 3779

10.1016/j.fct.2008.09.062

18940227

39.

Alvarez-Suarez

J.M.

Tulipani

Díaz

Estevez

Romandini

Giampieri

Damiani

Astolfi

Bompadre

Battino

Antioxidant and antimicrobial capacity of several monofloral Cuban honeys and their correlation with color, polyphenol content and other chemical compounds

Food Chem. Toxicol. 2010 48 2490 2499

10.1016/j.fct.2010.06.021

20558231

40.

Vit

Rodriguez-Malaver

Roubik

W.D.

Moreno

Souza

B.M.

Sancho

M.T.

Fernández-Muiño

Almeida-Anacleto

Marchini

L.C.

Gil

González

Aguilera

Nieves

Expanded parameters to assess the quality of honey from Venezuelan bees (Apis mellifera)

J. ApiProd. ApiMed. Sci. 2009 1 72 81

10.3896/IBRA.4.01.3.03

41.

Guerrinia

Brunib

Maiettia

Polic

Rossia

Paganettoa

Muzzolia

Scalvenzid

Sacchettia

Ecuadorian stingless bee (Meliponinae) honey: A chemical and functional profile of an ancient health product

Food Chem. 2009 114 1413 1420

10.1016/j.foodchem.2008.11.023

42.

Beretta

Orioli

Facino

R.M.

Antioxidant and radical scavenging activity of honey in endothelial cell cultures (EA.hy926)

Planta Med. 2007 73 1182 1189

10.1055/s-2007-981598

43.

Kishore

R.K.

Halim

A.S.

Syazana

M.S.

Sirajudeen

K.N.

Tualang honey has higher phenolic content and greater radical scavenging activity compared with other honey sources

Nutr. Res. 2011 31 322 325

10.1016/j.nutres.2011.03.001

21530807

44.

Eraslan

Kanbur

Silici

Karabacak

Beneficial effect of pine honey on trichlorfon induced some biochemical alterations in mice

Ecotoxicol. Environ. Saf. 2010 73 1084 1091

10.1016/j.ecoenv.2010.02.017

20303175

45.

Petrus

Schwartz

Sontag

Analysis of flavonoids in honey by HPLC coupled with coulometric electrode array detection and electrospray ionization mass spectrometry

Anal. Bioanal. Chem. 2011 400 2555 2563

10.1007/s00216-010-4614-7

21229237

46.

File:Syringic acid.png

(accessed on 11 April 2012)

Available online:http://en.wikipedia.org/wiki/File:Syringic_acid.png 47.

Bhor

V.M.

Sivakami

Regional variations in intestinal brush border membrane fluidity and function during diabetes and the role of oxidative stress and non-enzymatic glycation

Mol. Cell Biochem. 2003 252 125 132

10.1023/A:1025599126840

14577585

48.

Faria

Mateus

de Freitas

Calhau

Modulation of MPP+ uptake by procyanidins in Caco-2 cells: Involvement of oxidation/reduction reactions

FEBS Lett. 2006 580 155 160

10.1016/j.febslet.2005.11.068

16364314

49.

Faria

Monteiro

Pestana

Freitas

Mateus

Azevedo

Calhau

Intestinal oxidative state can alter nutrient and drug bioavailability

Oxid. Med. Cell. Longev. 2009 2 322 327

10.4161/oxim.2.5.9769

20716920

50.

Shirpoor

Ansari

M.H.

Salami

Pakdel

F.G.

Rasmi

Effect of vitamin E on oxidative stress status in small intestine of diabetic rat

World J. Gastroenterol. 2007 13 4340 4344

17708608

51.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Sirajudeen

K.N.

Salleh

M.S.

Gurtu

Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats

Int. J. Biol. Sci. 2011 7 244 252

21448302

52.

Ali

A.T.M.M.

Al-Humayyd

M.S.

Madan

B.R.

Natural honey prevents indomethacin- and ethanol-induced gastric lesions in rats

Saudi Med. J. 1990 11 275 279 53.

Gharzouli

Amira

Khennouf

Protective effect of mannitol, glucose-fructose-sucrose-maltose mixtureand natural honey hyperosmolar solutions against ethanol-induced gastric mucosal damage in rats

Exp. Toxicol. Pathol. 2001 53 175 180

10.1078/0940-2993-00175

11484836

54.

Mobarok

A.A.T.M.

Prevention of ammonia-induced gastric lesions in rats by natural honey

J. Nut. Environ. Med. 2003 13 239 246

10.1080/13590840310001649899

55.

Hung

C.R.

Effect of lysozyme chloride on betel quid chewing aggravated gastric oxidative stress and hemorrhagic ulcer in diabetic rats

World J. Gastroenterol. 2005 11 5853 5858

16270397

56.

Tandon

Khanna

H.D.

Dorababu

Goel

R.K.

Oxidative stress and antioxidants status in peptic ulcer and gastric carcinoma

Indian J. Physiol. Pharmacol. 2004 48 115 118

15270379

57.

Kim

Oxidative stress in Helicobacter pylori-induced gastric cell injury

Inflammopharmacology 2005 13 63 74

10.1163/156856005774423962

16259728

58.

Ali

A.T.

Chowdhury

M.N.

al Humayyd

M.S.

Inhibitory effect of natural honey on Helicobacter pylori

Trop. Gastroenterol. 1991 12 139 143

1841451

59.

Nzeako

B.C.

Al-Namaani

The antibacterial activity of honey on helicobacter pylori

Sultan Qaboos Univ. Med. J. 2006 6 71 76

21748138

60.

Harsch

I.A.

Brzozowski

Bazela

Konturek

S.J.

Kukharsky

Pawlik

Pawlowski

Hahn

E.G.

Konturek

P.C.

Impaired gastric ulcer healing in diabetic rats: Role of heat shock protein, growth factors, prostaglandins and proinflammatory cytokines

Eur. J. Pharmacol. 2003 481 249 260

10.1016/j.ejphar.2003.09.019

14642793

61.

Naito

Takagi

Oya-Ito

Okada

Suzuki

Hirata

Hirai

Uchiyama

Handa

Uchida

Yoshikawa

Impaired gastric ulcer healing in diabetic mice: Role of methylglyoxal

J. Physiol. Pharmacol. 2009 60 123 130

20400805

62.

Boehme

M.W.

Autschbach

Ell

Raeth

Prevalence of silent gastric ulcer, erosions or severe acute gastritis in patients with type 2 diabetes mellitus: A cross-sectional study

Hepatogastroenterology 2007 54 643 648

17523341

63.

Medhi

Prakash

Avti

P.K.

Saikia

U.N.

Pandhi

Khanduja

K.L.

Effect of Manuka honey and sulfasalazine in combination to promote antioxidant defense system in experimentally induced ulcerative colitis model in rats

Indian J. Exp. Biol. 2008 46 583 590

18814487

64.

Bilsel

Bugra

Yamaner

Bulut

Cevikbas

Turkoglu

Could honey have a place in colitis therapy? Effects of honey, prednisolone and disulfiram on inflammation, nitric oxide and free radical formation

Dig. Surg. 2002 19 306 311

10.1159/000064580

12207075

65.

Klip

Vranic

Muscle, liver and pancreas: Three Musketeers fighting to control glycemia

Am. J. Physiol. Endocrinol. MeTab. 2006 291 E1141 E1143

10.1152/classicessays.00043.2006

17082345

66.

Leeds

J.S.

Forman

E.M.

Morley

Scott

A.R.

Tesfaye

Sanders

D.S.

Abnormal liver function tests in patients with Type 1 diabetes mellitus: Prevalence, clinical correlations and underlying pathologies

Diabet. Med. 2009 26 1235 1241

20002475

67.

Dias

A.S.

Porawski

Alonso

Marroni

Collado

P.S.

Gonzalez-Gallego

Quercetin decreases oxidative stress, NF-kappaB activation and iNOS overexpression in liver of streptozotocin-induced diabetic rats

J. Nutr. 2005 135 2299 2304

16177186

68.

Gumieniczek

Oxidative stress in kidney and liver of alloxan-induced diabetic rabbits: Effect of repaglinide

Acta Diabetol. 2005 42 75 81

10.1007/s00592-005-0182-2

15944840

69.

Yao

L.K.

Razak

S.L.A.

Ismail

Fai

N.C.

Asgar

M.H.A.M.

Sharif

N.M.

Aan

G.J.

Jubri

Malaysian gelam honey reduces oxidative damage and modulates antioxidant enzyme activities in young and middle aged rats

J. Med. Plants Res. 2011 5 5618 5625 70.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Salam

S.K.

Salleh

M.S.

Gurtu

Hepatoprotective effect of tualang honey supplementation in streptozotocin-induced diabetic rats

Int. J. Appl. Res. Nat. Prod. 2012 4 37 41 71.

Al-Waili

N.S.

Intravenous and intrapulmonary administration of honey solution to healthy sheep: Effects on blood sugar, renal and liver function tests, bone marrow function, lipid profile and carbon tetrachloride-induced liver injury

J. Med. Food 2003 6 231 247

10.1089/10966200360716652

14585190

72.

Celebi

Yilmaz

Aksoy

Gumus

Taysi

Oren

Dehydroepiandrosterone prevents oxidative injury in obstructive jaundice in rats

J. Int. Med. Res. 2004 32 400 405

15303771

73.

Liu

T.Z.

Lee

K.T.

Chern

C.L.

Cheng

J.T.

Stern

Tsai

L.Y.

Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB

Ann. Clin. Lab. Sci. 2001 31 383 390

11688850

74.

Kilicoglu

Gencay

Kismet

Serin Kilicoglu

Erguder

Erel

Sunay

A.E.

Erdemli

Durak

Akkus

M.A.

The ultrastructural research of liver in experimental obstructive jaundice and effect of honey

Am. J. Surg. 2008 195 249 256

10.1016/j.amjsurg.2007.04.011

18083132

75.

Erguder

B.I.

Kilicoglu

S.S.

Namuslu

Kilicoglu

Devrim

Kismet

Durak

Honey prevents hepatic damage induced by obstruction of the common bile duct

World J. Gastroenterol. 2008 14 3729 3732

10.3748/wjg.14.3729

18595140

76.

Korkmaz

Kolankaya

Anzer honey prevents N-ethylmaleimide-induced liver damage in rats

Exp. Toxicol. Pathol. 2009 61 333 337

10.1016/j.etp.2008.07.005

18990552

77.

El Denshary

E.S.

Al-Gahazali

M.A.

Mannaa

F.A.

Salem

H.A.

Hassan

N.S.

Abdel-Wahhab

M.A.

Dietary honey and ginseng protect against carbon tetrachloride-induced hepatonephrotoxicity in rats

Exp. Toxicol. Pathol. 2011 [Epub ahead of print]. 78.

Poitout

Robertson

R.P.

Minireview: Secondary beta-cell failure in type 2 diabetes—A convergence of glucotoxicity and lipotoxicity

Endocrinology 2002 143 339 342

10.1210/en.143.2.339

11796484

79.

Evans

J.L.

Goldfine

I.D.

Maddux

B.A.

Grodsky

G.M.

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Diabetes 2003 52 1 8

10.2337/diabetes.52.1.1

80.

Grankvist

Marklund

S.L.

Taljedal

I.B.

CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse

Biochem. J. 1981 199 393 398

7041886

81.

Palsamy

Subramanian

Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stressand pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats

J. Cell. Physiol. 2010 224 423 432

10.1002/jcp.22138

20333650

82.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Sirajudeen

K.N.

Salleh

M.S.

Gurtu

Antioxidant protection of Malaysian tualang honey in pancreas of normal and streptozotocin-induced diabetic rats

Ann. Endocrinol. (Paris) 2010 71 291 296

10.1016/j.ando.2010.03.003

83.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Sirajudeen

K.N.

Salleh

M.S.

Gurtu

Effect of glibenclamide alone versus glibenclamide and honey on oxidative stress in pancreas of streptozotocin-induced diabetic rats

Int. J. Appl. Res. Nat. Prod. 2011 4 1 10 84.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Sirajudeen

K.N.

Salleh

M.S.

Gurtu

Antioxidant protective effect of glibenclamide and metformin in combination with honey in pancreas of streptozotocin-induced diabetic rats

Int. J. Mol. Sci. 2010 11 2056 2066

10.3390/ijms11052056

20559501

85.

Thomas

M.C.

Groop

P.H.

New approaches to the treatment of nephropathy in diabetes

Expert. Opin. Investig. Drugs 2011 20 1057 1071

10.1517/13543784.2011.591785

21745151

86.

Giacco

Brownlee

Oxidative stress and diabetic complications

Circ. Res. 2011 107 1058 1070 87.

Turan

Role of antioxidants in redox regulation of diabetic cardiovascular complications

Curr. Pharm. Biotechnol. 2011 11 819 836 88.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Sirajudeen

K.N.

Salleh

M.S.

Gurtu

Effects of Malaysian tualang honey supplementation on glycemia, free radical scavenging enzymes and markers of oxidative stress in kidneys of normal and streptozotocin-induced diabetic rats

Int. J. Cardiol. 2009 137 S45 89.

Perez

Rodriguez-Malaver

A.J.

Vit

Antioxidant capacity of Venezuelan honey in wistar rat homogenates

J. Med. Food. 2006 9 510 516

10.1089/jmf.2006.9.510

17201638

90.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Sirajudeen

K.N.

Salleh

M.S.

Gurtu

Effects of Malaysian tualang honey in combination with glibenclamide on blood glucose, body weight and oxidative stress in kidneys of streptozotocin-induced diabetic rats

Free Radic. Res. 2009 43 S49 S50 91.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Sirajudeen

K.N.

Salleh

M.S.

Gurtu

Comparison of antioxidant effects of honey, glibenclamide, metforminand their combinations in the kidneys of streptozotocin-induced diabetic rats

Int. J. Mol. Sci. 2011 12 829 843

10.3390/ijms12010829

21340016

92.

Rodrigo

Gonzalez

Paoletto

The role of oxidative stress in the pathophysiology of hypertension

Hypertens. Res. 2011 34 431 440

10.1038/hr.2010.264

21228777

93.

Lopes de Faria

J.B.

Silva

K.C.

Lopes de Faria

J.M.

The contribution of hypertension to diabetic nephropathy and retinopathy: The role of inflammation and oxidative stress

Hypertens. Res. 2011 34 413 422

10.1038/hr.2010.263

21228783

94.

Erejuwa

O.O.

Sulaiman

S.A.

Ab Wahab

M.S.

Sirajudeen

K.N.

Salleh

M.S.

Gurtu

Honey supplementation elicits antihypertensive effect in spontaneously hypertensive rats via amelioration of renal oxidative stress

Oxid. Med. Cell. Longev. 2012 2012 1 14 95.

Houston

M.C.

The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease

Ther. Adv. Cardiovasc. Dis. 2011 4 165 183 96.

Skrtic

Niklason

Leoo

Hedner

Risk factor identification and assessment in hypertension and diabetes (RIAHD) study

Blood Press. 2006 15 367 374

10.1080/08037050601103984

17472028

97.

Rosenthal

Younis

Alter

Combating combination of hypertension and diabetes in different rat models

Pharmaceuticals 2010 3 916 939

10.3390/ph3040916

98.

Friedman

Peleg

Kagan

Shnizer

Rosenthal

Oxidative stress in hypertensive, diabetic and diabetic hypertensive rats

Am. J. Hypertens. 2003 16 1049 1052

10.1016/j.amjhyper.2003.07.013

14643580

99.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Sirajudeen

K.N.

Salleh

M.S.

Gurtu

Differential responses to blood pressure and oxidative stress in streptozotocin-induced diabetic wistar-kyoto rats and spontaneously hypertensive rats: Effects of antioxidant (honey) treatment

Int. J. Mol. Sci. 2011 12 1888 1907

10.3390/ijms12031888

21673929

100.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Sirajudeen

K.N.

Salleh

M.S.

Gurtu

Influence of rat strains and/or severity of hyperglycemia on systolic blood pressure and antioxidant enzymes in kidney of rats with hypertension and/or diabetes: Role of honey

Int. J. Cardiol. 2011 152 S29 101.

Kim

H.J.

Vaziri

N.D.

Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure

Am. J. Physiol. Renal Physiol. 2010 298 F662 F671

10.1152/ajprenal.00421.2009

20007347

102.

Erejuwa

O.O.

Sulaiman

S.A.

Wahab

M.S.

Sirajudeen

K.N.

Salleh

M.S.

Gurtu

Impaired Nrf2-ARE pathway contributes to increased oxidative damage in kidney of spontaneously hypertensive rats: Effect of antioxidant (honey)

Int. J. Cardiol. 2011 152 S45 103.

Kobayashi

Iwamoto

Nakajima-Takagi

Kaneko

Nakayama

Eguchi

Wada

Kumagai

Yamamoto

The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds

Mol. Cell. Biol. 2009 29 493 502

10.1128/MCB.01080-08

19001094

104.

Rohlfing

C.L.

Wiedmeyer

H.M.

Little

R.R.

England

J.D.

Tennill

Goldstein

D.E.

Defining the relationship between plasma glucose and HbA1_C: Analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial

Diabetes Care 2002 25 275 278

10.2337/diacare.25.2.275

11815495

105.

O’Brien

R.C.

Luo

Balazs

Mercuri

In vitro and in vivo antioxidant properties of gliclazide

J. Diabetes Complicat. 2000 14 201 206

10.1016/S1056-8727(00)00084-2

11004429

106.

Jain

S.K.

Lim

Pyridoxine and pyridoxamine inhibits superoxide radicals and prevents lipid peroxidation, protein glycosylationand (Na⁺ + K⁺)-ATPase activity reduction in high glucose-treated human erythrocytes

Free Radic. Biol. Med. 2001 30 232 237

10.1016/S0891-5849(00)00462-7

11165869

107.

Fasanmade

A.A.

Alabi

O.T.

Differential effect of honey on selected variables in alloxan-induced and fructose-induced diabetic rats

Afr. J. Biomed. Res. 2008 11 191 196 108.

Selvaraj

Bobby

Sathiyapriya

Effect of lipid peroxides and antioxidants on glycation of hemoglobin: An in vitro study on human erythrocytes

Clin. Chim. Acta 2006 366 190 195

10.1016/j.cca.2005.10.002

16325165

109.

Gheldof

Wang

X.H.

Engeseth

N.J.

Buckwheat honey increases serum antioxidant capacity in humans

J. Agric. Food Chem. 2003 51 1500 1505

10.1021/jf025897t

12590505

110.

Balamurugan

Bobby

Selvaraj

Nalini

Koner

B.C.

Sen

S.K.

Increased protein glycation in non-diabetic pediatric nephrotic syndrome: Possible role of lipid peroxidation

Clin. Chim. Acta 2003 337 127 132

10.1016/j.cccn.2003.07.007

14568188

111.

Ceriello

Giugliano

Quatraro

Donzella

Dipalo

Lefebvre

P.J.

Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications?

Diabetes Care 1991 14 68 72

10.2337/diacare.14.1.68

1991440

112.

Vinson

J.A.

Howard

T.B.

Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients

J. Nutr. Biochem. 1996 7 659 663

10.1016/S0955-2863(96)00128-3

113.

Chepulis

Starkey

The long-term effects of feeding honey compared with sucrose and a sugar-free diet on weight gain, lipid profiles and DEXA measurements in rats

J. Food Sci. 2008 73 H1 H7

10.1111/j.1750-3841.2007.00641.x

18211352

114.

Al-Waili

N.S.

Natural honey lowers plasma glucose, C-reactive protein, homocysteine and blood lipids in healthy, diabetic and hyperlipidemic subjects: Comparison with dextrose and sucrose

J. Med. Food 2004 7 100 107

10.1089/109662004322984789

15117561

115.

Yaghoobi

Al-Waili

Ghayour-Mobarhan

Parizadeh

S.M.

Abasalti

Yaghoobi

Esmaeili

Kazemi-Bajestani

S.M.

Aghasizadeh

Saloom

K.Y.

Ferns

G.A.

Natural honey and cardiovascular risk factors; effects on blood glucose, cholesterol, triacylglycerole, CRP and body weight compared with sucrose

ScientificWorldJournal 2008 8 463 469

10.1100/tsw.2008.64

116.

Bahrami

Ataie-Jafari

Hosseini

Foruzanfar

M.H.

Rahmani

Pajouhi

Effects of natural honey consumption in diabetic patients: An 8-week randomized clinical trial

Int. J. Food Sci. Nutr. 2009 60 618 626

10.3109/09637480801990389

19817641

117.

Mabrouk

G.M.

Moselhy

S.S.

Zohny

S.F.

Ali

E.M.

Helal

T.E.

Amin

A.A.

Khalifa

A.A.

Inhibition of methylnitrosourea (MNU)-induced oxidative stress and carcinogenesis by orally administered bee honey and Nigella grains in Sprague Dawely rats

J. Exp. Clin. Cancer Res. 2002 21 341 346

12385575

118.

Al-Waili

N.S.

Identification of nitric oxide metabolites in various honeys: Effects of intravenous honey on plasma and urinary nitric oxide metabolites concentrations

J. Med. Food. 2003 6 359 364

10.1089/109662003772519921

14977445

119.

Hassan

A.I.

Bayoumi

M.M.

Efficiency of camel milk and honey bee in alleviation of diabetes in rats

Nat. Sci. 2010 8 333 341 120.

Rajpurkar

Jiang

Dhabuwala

C.B.

Dunbar

J.C.

Cigarette smoking induces apoptosis in rat testis

J. Environ. Pathol. Toxicol. Oncol. 2002 21 243 248

12435077

121.

Rajpurkar

Dhabuwala

C.B.

Jiang

Chronic cigarette smoking induces an oxidant/antioxidant imbalance in the testis

J. Environ. Pathol. Toxicol. Oncol. 2000 19 369 373

11213019

122.

Agarwal

Prabakaran

S.A.

Said

T.M.

Prevention of oxidative stress injury to sperm

J. Androl. 2005 26 654 660

10.2164/jandrol.05016

16291955

123.

Mohamed

Sulaiman

S.A.

Jaafar

Sirajudeen

K.N.

Antioxidant protective effect of honey in cigarette smoke-induced testicular damage in rats

Int. J. Mol. Sci. 2011 12 5508 5521

10.3390/ijms12095508

22016605

124.

Asiyah

H.A.

Syazana

N.S.

Hashida

N.H.

Durriyyah Sharifah

H.A.

Kamaruddin

M.Y.

Effects of nicotine and Gelam honey on testisparameters and sperm qualities of juvenile rats

Sci. Res. Essays 2011 6 5471 5474 125.

Abdul-Ghani

A.S.

Dabdoub

Muhammad

Abdul-Ghani

Qazzaz

Effect of Palestinian honey on spermatogenesis in rats

J. Med. Food 2008 11 799 802

10.1089/jmf.2008.0085

19053876

126.

Tartibian

Hajizadeh Maleki

Abbasi

The effects of honey supplementation on seminal plasma cytokines, oxidative stress biomarkers and anti-oxidants during 8 weeks of intensive cycling training

J. Androl. 2011

10.2164/jandrol.110.012815

127.

Gakhramanov

F.S.

Effect of natural antioxidants on antioxidant activity and lipid peroxidation in eye tissue of rabbits with chemical burns

Bull. Exp. Biol. Med. 2005 140 289 291

10.1007/s10517-005-0469-x

16307038

128.

Gakhramanov

F.S.

Kerimov

K.T.

Dzhafarov

A.I.

Use of natural antioxidants for the correction of changes in general and local parameters of lipid peroxidation and antioxidant defense system during experimental eye burn

Bull. Exp. Biol. Med. 2006 142 696 699

10.1007/s10517-006-0454-z

17603673

129.

Bashkaran

Zunaina

Bakiah

Sulaiman

S.A.

Sirajudeen

K.N.

Naik

Anti-inflammatory and antioxidant effects of Tualang honey in alkali injury on the eyes of rabbits: Experimental animal study

BMC Complement. Altern. Med. 2011 11 1 90

21199573

130.

Jankauskiene

Jarushaitiene

Cheksteryte

Rachys

Using 20% honey solution eye drops in patients with dry eye syndrome

J. Apicult. Res. 2007 46 232 235 131.

Cernak

Majtanova

Cernak

Majtan

Honey prophylaxis reduces the risk of endophthalmitis during perioperative period of eye surgery

Phytother. Res. 2011

10.1002/ptr.3606

132.

Busserolles

Gueux

Rock

Mazur

Rayssiguier

Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose

J. Nutr. 2002 132 3379 3382

12421854

133.

Nemoseck

T.M.

Carmody

E.G.

Furchner-Evanson

Gleason

Potter

Rezende

L.M.

Lane

K.J.

Kern

Honey promotes lower weight gain, adiposity and triglycerides than sucrose in rats

Nutr. Res. 2011 31 55 60

10.1016/j.nutres.2010.11.002

21310307

134.

Razquin

Martinez

J.A.

Martinez-Gonzalez

M.A.

Mitjavila

M.T.

Estruch

Marti

A 3 years follow-up of a Mediterranean diet rich in virgin olive oil is associated with high plasma antioxidant capacity and reduced body weight gain

Eur. J. Clin. Nutr. 2009 63 1387 1393

10.1038/ejcn.2009.106

19707219

135.

Peake

J.M.

Suzuki

Coombes

J.S.

The influence of antioxidant supplementation on markers of inflammation and the relationship to oxidative stress after exercise

J. Nutr. Biochem. 2007 18 357 371

10.1016/j.jnutbio.2006.10.005

17156994

136.

Kassim

Achoui

Mansor

Yusoff

K.M.

The inhibitory effects of Gelam honey and its extracts on nitric oxide and prostaglandin E(2) in inflammatory tissues

Fitoterapia 2011 81 1196 1201 137.

Owoyele

B.V.

Adenekan

O.T.

Soladoye

A.O.

Effects of honey on inflammation and nitric oxide production in Wistar rats

Zhong Xi Yi Jie He Xue Bao 2011 9 447 452

10.3736/jcim20110415

21486559

138.

Köhler

H.F.

Delucca

I.M.

Sbragia Neto

Enteral antioxidants in ischemia/reperfusion injuries in rats

Rev. Col. Bras. Cir. 2011 38 422 428

22267141

139.

Rodrigo

Prat

Passalacqua

Araya

Bächler

J.P.

Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension

Clin. Sci. 2008 114 625 634

10.1042/CS20070343

17999638

140.

Shargorodsky

Debby

Matas

Zimlichman

Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors

Nutr. Metab. 2010 7 55

10.1186/1743-7075-7-55

141.

J.L.

Zhang

Brown

L.M.

J.Y.

Shen

Pan

K.F.

Liu

W.D.

Han

Z.X.

Crystal-Mansour

Pee

Blot

W.J.

Fraumeni

J.F.

Jr. You

W.C.

Gail

M.H.

Fifteen-year effects of Helicobacter pylori, garlic and vitamin treatments on gastric cancer incidence and mortality

J. Natl. Cancer Inst. 2012

10.1093/jnci/djs003

142.

Singh

P.P.

Chandra

Mahdi

Roy

Sharma

Reconvene and reconnect the antioxidant hypothesis in human health and disease

Indian J. Clin. Biochem. 2010 25 225 243

10.1007/s12291-010-0078-y

21731194

143.

Rietjens

I.M.

Boersma

M.G.

Haan

Spenkelink

Awad

H.M.

Cnubben

N.H.

van Zanden

J.J.

Woude

Alink

G.M.

Koeman

J.H.

The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids

Environ. Toxicol. Pharmacol. 2002 11 321 333

10.1016/S1382-6689(02)00003-0

21782615

144.

Halliwell

Vitamin C: Antioxidant or pro-oxidant in vivo?

Free Radic. 1996 25 439 454

10.3109/10715769609149066

145.

Bowry

V.W.

Ingold

K.U.

Stocker

Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant

Biochem. J. 1992 288 Pt 2 341 344

1463440

146.

Pearson

Lewis

S.A.

Britton

Young

I.S.

Fogarty

The pro-oxidant activity of high-dose vitamin E supplements in vivo

BioDrugs 2006 20 271 273

17025373

147.

Heinonen

O.P.

Albanes

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

N. Engl. J. Med. 1994 330 1029 1035

8127329

148.

Handelman

G.J.

Machlin

L.J.

Fitch

Weiter

J.J.

Dratz

E.A.

Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans

J. Nutr. 1985 115 807 813

3998871

149.

Mitchel

R.E.

McCann

Vitamin E is a complete tumor promoter in mouse skin

Carcinogenesis 1993 14 659 662

8472330

150.

Christen

Woodall

A.A.

Shigenaga

M.K.

Southwell-Keely

P.T.

Duncan

M.W.

Ames

B.N.

Gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: Physiological implications

Proc. Natl. Acad. Sci. USA 1997 94 3217 3222

9096373

151.

Cooney

R.V.

Franke

A.A.

Harwood

P.J.

Hatch-Pigott

Custer

L.J.

Mordan

L.J.

Gamma-tocopherol detoxification of nitrogen dioxide: Superiority to alpha-tocopherol

Proc. Natl. Acad. Sci. USA 1993 90 1771 1775

8446589

152.

Vaziri

N.D.

Causal link between oxidative stress, inflammation and hypertension

Iran J. Kidney Dis. 2008 2 1 10

19367002